Profile of Secondary Bone Cancer in Lomé (Togo)


Objectives: To determine the epidemiological, clinical and paraclinical profile of bone metastases cancer. Patients and Methods: It was a retrospective study performed on a series of cases, admitted in Rheumatology department of the University Teaching Hospital of Lomé, Togo from October 1989 to December 2008. The diagnosis of bone metastasis was made because of the existence of inflammatory bone pain, or pathological fracture, or bone swelling and a bone condensing or mixed or osteolytic radiological image. The anatomopathological evidence was made after biopsy of the bone lesion or primary cancer. 2018 patients were hospitalized in rheumatology, and among them 77 had documented bone metastasis. Results: There were 53 men (68.8%) and 24 women (31.2%) with a sex ratio of 2.2. The mean age was 56.6 ± 12.6 years, ranging from 21 to 82 years. The primary cancer most frequently found was that of the prostate, representing 57.1% of bone metastasis and breast in 15.6%. The main manifestations of patients with bone metastases were inflammatory bone pain (76.6%) and alteration of general condition (75.3%). The spine was the main area of pain (64.9%). The metastasis was bone condensing in 48.1% of cases, osteolytic in 40.3% and mixed in 11.6%. The average survival was 22 months. Conclusion: The clinical and radiological presentation remains classic. Cancer of the prostate and breast are the main neoplasia responsible for bone metastasis in our series. The diagnosis of the primary tumor is often made at the stage of metastasis in black Africa.

Share and Cite:

Oniankitan, O. , Kakpovi, K. , Kpoti, M. , Houzou, P. , Fianyo, E. , Koffi-Tessio, V. , Tagbor, K. and Mijiyawa, M. (2014) Profile of Secondary Bone Cancer in Lomé (Togo). Open Journal of Rheumatology and Autoimmune Diseases, 4, 192-197. doi: 10.4236/ojra.2014.43026.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Jemal, A., Tiwari, R.C., Murray, T., Samuels, A., Ward, E., Feuer, E.J. and Thun, M.J. (2004) Cancer Statistics 2004. CA: A Cancer Journal for Clinicians, 54, 8-29.
[2] Virk, M.S. and Lieberman, J.R. (2007) Tumor Metastasis to Bone. Arthritis Research and Therapy, 9, 10.
[3] Li, K.K., Sinclair, E., Pope, J., et al. (2008) A Multidisciplinary Bone Metastases Clinic at Toronto Sunnybrook Regional Cancer Centre. A Review of the Experience from 1999 to 2005. Journal of Pain Research, 1, 43-48.
[4] Gremaud, M., Delouche, D., Monnerat, C., et al. (2006) Treatment of Bone Metastases with Bisphosphonates. Revue Médicale Suisse A, 2, 1861-1866.
[5] Bahebeck, J., Atangana, R., Eyenga, V., et al. (2003) Bones Tumors in Cameroon: Incidence, Demography and Histopathology. International orthopaedics, 27, 315-317.
[6] Sarma, N.H., Al-fituri, O., Visweswara, R.N., et al. (1994) Primary Bone Tumor in Eastern Libya, a 10 Year Study. The Central African journal of medicine, 40, 148-151.
[7] Abdulkareem, F.B., Evesan, S.U., Akinde, O.R., et al. (2007) Pathological Studies of Bone Tumors at the National Orthopaedic Hospital, Lagos, Nigeria. Western African Journal of Medicine, 26, 306-311.
[8] Bileckot, R., Miakoundoba, R.C. and Nkoua-Mbon, J.B. (2008) Two Brazzaville Series of Bone Metastases. Carcinol Prat Afrique, 8, 57-60.
[9] Ly, M., Ly, A., Rodrigues, M., et al. (2010) Cancer in Africa, a New Health Challenge. Examples of Mali and Mali Onco Association. Bull Cancer, 97, 965.
[10] Gombe-Mbalawa, C. and Ibara, G. (2011) Report Functioning Cancer Registry of Brazzaville from January 1st to December 31st 2010. Cancer Registry of Brazzaville, 2011.
[11] Belaksir, L., Seknaji, N., Touimy, M., Janani, S., et al. (2010) Bone Metastases: Experience of Rheumatology CHU Ibn Rushd at Casa. Revue du Rhumatisme, 77, A131-A325.
[12] Ntsiba, H., N’soundhat, N.E.L., Ndounga, E. and Ondzal, A.E. (2013) Profile of Secondary Bone Cancer in Brazzaville. Open Journal of Rheumatology and Autoimmune Diseases, 3, 251-254.
[13] Seknaji, N., Touimy, M., Belksir, L., et al. (2010) Contribution of Bone Biopsy in Search of Primary Cancer of Bone Metastases. Revue Du Rhumatisme, 77, A131-A325.
[14] Houze, P., Ranaivosoar, R., Prost, A.C., et al. (1995) Bone Metastases of Prostate Cancer: Contribution of Specific Determination of Bone Alkaline Phosphatase. Immuno-Analyse & Biologie Specialisee, 10, 27-33.
[15] Vandecandelaere, M., Filipo, R.M., Cortet, B., Catanzariti, L., Duquesnoy, B. and Delcambre, B. (2004) Bone Metastases Revealing: A Comparative Study in 30-Years Intervals. Revue Du Rhumatisme, 71, 390-396.
[16] Gombe-Mbalawa, C., Diouf, D., Mbon, J.B.N., et al. (2013) Arrival of Cancer Patients in Advanced Stages: Attempted Identification of Responsibility. Bull Cancer, 100, 167-171.
[17] Vandecandelaere, M., Flipo, R.M., Cortet, B., Catanzariti, L., Duquesnoy, B., Delcambre, B. (2004) Bone Metastasis Revealing Primary Tumor. Comparison of Two Series Separated by 30 Years. Joint Bone Spine, 71, 224-229.
[18] Kouakoué, N. (1994) Bone Metastasis in Ivory Coast Hospital. Rhumatologie (Aix-les-Bains) A, 46, 243-245.
[19] Daboiko, J.C., Eti, E., Dollo, Y.I., Ouali, B., Ouattara, B. and Kouakou, N.M. (2004) Inflammatory Rheumatic Diseases at Cocody University Medical Center (Abidjan) from March 1998 to March 2000. Joint, Bone, Spine, 71, 598-599.
[20] Belhaj, R., Boussen, H., Ghanem, A., Essafer, S., Harzallah, L., Ayed, F.B., et al. (2002) Bioclinical Correlations in Bony Metastases. Results of a Prospective Study. 60 Cases. La Tunisie médicale, 80, 691-695.
[21] Hindié, E., Zanotti-Fregonara, P., Keller, I., Duron, F., Devaux, J.Y., Calzada-Nocaudie, M., et al. (2007) Bone Metastases of Differentiated Thyroid Cancer: Impact of Early 131I-Based Detection on Outcome. Endocrine Related Cancer, 14, 799-807.
[22] Proust, C., Proust, J. and Maubon, A. (2006) Imaging Bone Metastases. Nuclear Medicine. Functional and Metabolic Imaging, 30, 149-154.
[23] Belaksir, L., Touimy, M., Janani, S., et al. (2010) Revealing Bone Metastasis of Prostate Cancer. Revue Du Rhumatisme, 77, A131-A325.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.